Docebo (DCBO) Cost of Revenue (2019 - 2026)

Docebo (DCBO) has reported Cost of Revenue for 8 consecutive years, with $14.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cost of Revenue rose 21.86% year-over-year to $14.1 million; the trailing twelve-month figure through Jun 2026 stood at $53.3 million (up 20.98% YoY), and the FY2025 full-year result was $47.9 million, up 15.88% from the prior year.
• Cost of Revenue retreated to $14.1 million in Q2 2026 per DCBO's latest filing, from $14.4 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $14.4 million in Q1 2026 and bottomed at $6.6 million in Q1 2022.
• Historically, Cost of Revenue has averaged $10.0 million across 5 years, with a median of $10.1 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Cost of Revenue jumped 69.57% in 2022, then gained 12.94% in 2025.
• Over 5 years, Cost of Revenue stood at $7.5 million in 2022, then climbed by 23.28% to $9.3 million in 2023, then climbed by 15.07% to $10.6 million in 2024, then rose by 19.62% to $12.7 million in 2025, then grew by 10.8% to $14.1 million in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $14.1 million, $14.4 million, and $12.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.